Evidence map›Paper›PMID 21614028›Full record

ArticleGene therapy2012

Transgene-mediated expression of tumor necrosis factor soluble receptor attenuates morphine tolerance in rats.

J Sun, S Liu, M Mata, D J Fink, S Hao

Open access · greenAbstract read
In one paragraph

Article in Gene therapy, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Neuronal and glial factors contributing to sex differences in opioid modulation of pain.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2019
    Review
  6. Article
  7. Article
  8. Toll-like Receptor 4 Mediates Morphine-Induced Neuroinflammation and Tolerance via Soluble Tumor Necrosis Factor Signaling.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2017
    Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

J SunDepartment of Neurology, University of Michigan, Ann Arbor, MI, USA.
S Liu
M Mata
D J Fink
S Hao
University of Michigan–Ann Arbor · USUniversity of Miami · US

Funding

PRE-CLINICAL VECTOR PRODUCTIONP01DK044935 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI GLORIOSO, JOSEPH C · 1993 to 2010
$11.8M
GENE TRANSFER FOR PREVENTION OF DIABETIC NEUROPATHYR01NS038850 · NINDS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI FINK, DAVID J. · 1999 to 2012
$3.3M
Gene Therapy for PainR01NS044507 · NINDS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI FINK, DAVID J. · 2002 to 2005
$1.8M
HIV and NRTI's-induced painful pathogenic mechanisms and gene therapyR01NS066792 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI HAO, SHUANGLIN · 2010 to 2014
$1.6M
Pathogenesis and Therapy of HIV-Related Neuropathic PainR21DA025527 · NIDA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI HAO, SHUANGLIN · 2009 to 2010
$423k
Gene therapy of HIV-neuropathic pain with morphine toleranceR03DA026734 · NIDA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI HAO, SHUANGLIN · 2009 to 2010
$309k
Transgene for morphine tolerance and withdrawalR03DA020078 · NIDA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI HAO, SHUANGLIN · 2005 to 2005
$77k
NIDA NIH HHS DA020078NIDA NIH HHS DA025527NIDA NIH HHS DA026734NIDA NIH HHS R03 DA020078NIDA NIH HHS R03 DA026734NIDA NIH HHS R21 DA025527NIDDK NIH HHS DK044935NIDDK NIH HHS P01 DK044935NINDS NIH HHS NS038850NINDS NIH HHS NS066792NINDS NIH HHS R01 NS038850NINDS NIH HHS R01 NS044507NINDS NIH HHS R01 NS066792
6 · The paper itself

Abstract

Opiate/narcotic analgesics are the most effective treatments for chronic severe pain, but their clinical utility is often hampered by the development of analgesic tolerance. Recent evidence suggests chronic morphine may activate glial cells to release proinflammatory cytokines. In this study, we used herpes simplex virus (HSV) vector-based gene transfer to dorsal root ganglion to produce a local release of p55 tumor necrosis factor (TNF) soluble receptor in the spinal cord in rats with morphine tolerance. Subcutaneous inoculation of HSV vectors expressing p55 TNF soluble receptor into the plantar surface of the hindpaws enhanced the antinociceptive effect of acute morphine in rats. Subcutaneous inoculation of those vectors into hindpaws also delayed the development of chronic morphine tolerance in rats. TNF soluble receptor expressed by HSV vector reduced gene transcription of spinal TNFα and interleukin-1β (IL-1β) induced by repeated morphine. Furthermore, we found that TNF soluble receptor mediated by HSV reversed the upregulation of protein level of TNFα and IL-1β and phosphorylation of p38 mitogen-activated protein kinase induced by repeated morphine. These results support the concept that proinflammatory cytokines may have an important role in the pathogenesis induced by morphine. This study provides a novel approach to treating morphine tolerance.

Indexed as

Drug ToleranceTransgenesAnalgesicsAnimalsBehavior, AnimalGanglia, SpinalGene Expression RegulationGenetic TherapyGenetic VectorsGene Transfer TechniquesInjections, SubcutaneousInterleukin-1betaMaleMorphinep38 Mitogen-Activated Protein KinasesPhosphorylationAnalgesicsInterleukin-1betaMorphinep38 Mitogen-Activated Protein KinasesReceptors, Tumor Necrosis Factor

Identifiers

PMID21614028
PMCPMC3175012
OpenAlexW2074066446

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.